RESUMO
La pandemia por SARS-CoV-2 ha generado nuevos escenarios que requieren modificaciones de los protocolos habituales de reanimación cardiopulmonar. Las guías clínicas vigentes sobre el manejo de la parada cardiorrespiratoria no incluyen recomendaciones para situaciones aplicables a este contexto. Por ello, el Plan Nacional de Reanimación Cardiopulmonar de la Sociedad Española de Medicina Intensiva, Crítica y Unidades Coronarias, en colaboración con el Grupo Español de RCP Pediátrica y Neonatal y con el programa de Enseñanza de Soporte Vital en Atención Primaria de la Sociedad Española de Medicina Familiar y Comunitaria, ha redactado las siguientes recomendaciones, que están divididas en 5 partes que tratan los principales aspectos para cada entorno asistencial. En este artículo se presenta un resumen ejecutivo de las mismas
The SARS-CoV-2 pandemic has created new scenarios that require modifications to the usual cardiopulmonary resuscitation protocols. The current clinical guidelines on the management of cardiorespiratory arrest do not include recommendations for situations that apply to this context. Therefore, the National Cardiopulmonary Resuscitation Plan of the Spanish Society of Intensive and Critical Care Medicine and Coronary Units (SEMICYUC), in collaboration with the Spanish Group of Pediatric and Neonatal CPR and with the Teaching Life Support in Primary Care program of the Spanish Society of Family and Community Medicine (SEMFyC), have written these recommendations, which are divided into 5 parts that address the main aspects for each healthcare setting. This article consists of an executive summary of them
Assuntos
Humanos , Infecções por Coronavirus/diagnóstico , Reanimação Cardiopulmonar/normas , Reanimação Cardiopulmonar/instrumentação , Parada Cardíaca/complicações , Reação em Cadeia da Polimerase , Sociedades Médicas/normas , Segurança do Paciente , Infecções Respiratórias/prevenção & controle , Infecções Respiratórias/transmissãoRESUMO
The SARS-CoV-2 pandemic has created new scenarios that require modifications to the usual cardiopulmonary resuscitation protocols. The current clinical guidelines on the management of cardiorespiratory arrest do not include recommendations for situations that apply to this context. Therefore, the National Cardiopulmonary Resuscitation Plan of the Spanish Society of Intensive and Critical Care Medicine and Coronary Units (SEMICYUC), in collaboration with the Spanish Group of Pediatric and Neonatal CPR and with the Teaching Life Support in Primary Care program of the Spanish Society of Family and Community Medicine (SEMFyC), have written these recommendations, which are divided into 5 parts that address the main aspects for each healthcare setting. This article consists of an executive summary of them.
Assuntos
COVID-19/complicações , Reanimação Cardiopulmonar/normas , SARS-CoV-2 , Adulto , Suporte Vital Cardíaco Avançado/métodos , Suporte Vital Cardíaco Avançado/normas , Fatores Etários , Manuseio das Vias Aéreas/métodos , Manuseio das Vias Aéreas/normas , COVID-19/epidemiologia , COVID-19/prevenção & controle , COVID-19/transmissão , Reanimação Cardiopulmonar/métodos , Criança , Progressão da Doença , Cardioversão Elétrica , Parada Cardíaca/terapia , Humanos , Pandemias , Posicionamento do Paciente/métodos , Equipamento de Proteção Individual , Roupa de Proteção , Sociedades Médicas , EspanhaRESUMO
El Síndrome de Patau, también conocido comotrisomía D o trisomía 13, está causado por una mutacióndel cromosoma 13 con alteración de la divisióncelular, constituyendo la tercera cromosomopatíaen frecuencia. A continuación se describe el casode un recién nacido mujer con múltiples anomalíascongénitas al nacimiento compatible con síndromede Patau, que carece de diagnóstico antenatal, confirmándoseposteriormente mediante estudio genético(cariotipo). Diferentes guías diagnósticas, quedescriben patrones de reconocimiento, son útilespara identificar síndromes con sintomatología diversa.Debido a los cambios poblacionales en los últimosaños, se ha incrementado el número de embarazosno controlados, lo que supone el aumento desíndromes dismórficos diagnosticados al nacimiento.Es de gran importancia definir el manejo de estosniños en consenso con sus progenitores por su evolucióntórpida y fatal desenlace en la mayoría de loscasos
Patau syndrome, known as D trisomy or trisomy13, is caused by a mutation in chromosome 13 withaltered cellular division. It is the third most frequentchromosomopathy. We report a female newborn withoutantenatal diagnosis presented at birth with multiplecongenital anomalies compatible with Patausyndrome, which is confirmed later by cytogeneticstudies (cariotype). Different diagnostic guidelinesthat describe recognition patterns are useful to identifysyndromes with diverse symptomatology. Due topopulation changes in last years, there is an increasednumber of no controlled pregnancies resulting inmore diagnosis of dysmorphic syndromes presentedat birth. Is essential to define the management ofthese children in consensus with parents because of their omminous evolution and fatal outcome in mostcases (AU)
Assuntos
Humanos , Feminino , Recém-Nascido , Trissomia/diagnóstico , Cromossomos Humanos Par 13/genética , Microcefalia/genética , Fenda Labial/genética , Fissura Palatina/genética , Displasia Ectodérmica/genéticaRESUMO
No disponible
